These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 21080810)

  • 1. Validation of a quality of life questionnaire in the Pacific Island.
    O'Connor PM; Scarr BC; Lamoureux EL; Le Mesurier RT; Keeffe JE
    Ophthalmic Epidemiol; 2010 Dec; 17(6):378-86. PubMed ID: 21080810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Dutch ICF version of the Activity Inventory: results from focus groups with visually impaired persons and experts.
    Bruijning J; van Nispen R; Verstraten P; van Rens G
    Ophthalmic Epidemiol; 2010 Dec; 17(6):366-77. PubMed ID: 21090911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of the impact of vision impairment.
    Weih LM; Hassell JB; Keeffe J
    Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):927-35. PubMed ID: 11923230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of vision impairment on vision-specific quality of life in Germany.
    Finger RP; Fenwick E; Marella M; Dirani M; Holz FG; Chiang PP; Lamoureux EL
    Invest Ophthalmol Vis Sci; 2011 Jun; 52(6):3613-9. PubMed ID: 21357395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health risk profile for older adults with blindness: an application of the International Classification of Functioning, Disability, and Health framework.
    Jones GC; Crews JE; Danielson ML
    Ophthalmic Epidemiol; 2010 Dec; 17(6):400-10. PubMed ID: 21090913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The determinants of participation in activities of daily living in people with impaired vision.
    Lamoureux EL; Hassell JB; Keeffe JE
    Am J Ophthalmol; 2004 Feb; 137(2):265-70. PubMed ID: 14962415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of visual impairment on quality of life: a comparison with quality of life in the general population and with other chronic conditions.
    Langelaan M; de Boer MR; van Nispen RM; Wouters B; Moll AC; van Rens GH
    Ophthalmic Epidemiol; 2007; 14(3):119-26. PubMed ID: 17613846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Quality of life of visually impaired adults after low-vision intervention: a pilot study].
    Fintz AC; Gottenkiene S; Speeg-Schatz C
    J Fr Ophtalmol; 2011 Oct; 34(8):526-31. PubMed ID: 21632149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a vision-specific quality-of-life questionnaire for Timor-Leste.
    du Toit R; Palagyi A; Ramke J; Brian G; Lamoureux EL
    Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4284-9. PubMed ID: 18502996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Participation of the elderly after vision loss.
    Alma MA; van der Mei SF; Melis-Dankers BJ; van Tilburg TG; Groothoff JW; Suurmeijer TP
    Disabil Rehabil; 2011; 33(1):63-72. PubMed ID: 20518624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of Vision Impairment Questionnaire: an evaluation of its measurement properties using Rasch analysis.
    Lamoureux EL; Pallant JF; Pesudovs K; Hassell JB; Keeffe JE
    Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):4732-41. PubMed ID: 17065481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effectiveness of low-vision rehabilitation on participation in daily living and quality of life.
    Lamoureux EL; Pallant JF; Pesudovs K; Rees G; Hassell JB; Keeffe JE
    Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1476-82. PubMed ID: 17389474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing participation in daily living and the effectiveness of rehabiliation in age related macular degeneration patients using the impact of vision impairment scale.
    Lamoureux EL; Pallant JF; Pesudovs K; Tennant A; Rees G; O'Connor PM; Keeffe JE
    Ophthalmic Epidemiol; 2008; 15(2):105-13. PubMed ID: 18432494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vision and quality of life: the development of a utility measure.
    Misajon R; Hawthorne G; Richardson J; Barton J; Peacock S; Iezzi A; Keeffe J
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4007-15. PubMed ID: 16249474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development and evaluation of psychometric tests of the Chinese-version of low vision quality of life questionnaire].
    Zou HD; Zhang X; Xu X; Bai L
    Zhonghua Yan Ke Za Zhi; 2005 Mar; 41(3):246-51. PubMed ID: 15840368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measuring low vision service outcomes: Rasch analysis of the seven-item National Eye Institute Visual Function Questionnaire.
    Ryan B; Court H; Margrain TH
    Optom Vis Sci; 2008 Feb; 85(2):112-21. PubMed ID: 18296928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The psychometric validity of the NEI VFQ-25 for use in a low-vision population.
    Marella M; Pesudovs K; Keeffe JE; O'Connor PM; Rees G; Lamoureux EL
    Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):2878-84. PubMed ID: 20089878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the FACT-Gastric cancer quality of life questionnaire for use in Spanish-speaking countries.
    Debb SM; Arnold B; Perez B; Cella D
    Psychooncology; 2011 Jan; 20(1):19-27. PubMed ID: 20217836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developing the impact of Vision Impairment-Very Low Vision (IVI-VLV) questionnaire as part of the LoVADA protocol.
    Finger RP; Tellis B; Crewe J; Keeffe JE; Ayton LN; Guymer RH
    Invest Ophthalmol Vis Sci; 2014 Sep; 55(10):6150-8. PubMed ID: 25190656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impact of Vision Impairment for Children (IVI_C): validation of a vision-specific pediatric quality-of-life questionnaire using Rasch analysis.
    Cochrane GM; Marella M; Keeffe JE; Lamoureux EL
    Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1632-40. PubMed ID: 21178144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.